You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • OP0077 Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Psoriatic Arthritis with and without Prior Anti-Tumor Necrosis Factor Exposure: 96-Week Outcomes from the Rapid-Psa Trial

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Oral Presentations. Abstract session: Genes, disease activity and treatment of psoriatic arthritis
OP0077 Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Psoriatic Arthritis with and without Prior Anti-Tumor Necrosis Factor Exposure: 96-Week Outcomes from the Rapid-Psa Trial

 

Online download statistics by month:

Online download statistics by month: June 2014 to March 2024

AbstractFullPdf
Jun 20141200
Jul 2014700
Aug 20141102
Sep 20141302
Oct 20143201
Nov 20142502
Dec 20141403
Jan 2015100
Feb 2015602
Mar 2015801
Apr 2015700
May 2015800
Jun 2015300
Jul 2015701
Aug 2015600
Sep 20151001
Oct 20151501
Nov 2015402
Dec 2015801
Jan 2016800
Feb 2016800
Mar 20161101
Apr 20161303
May 2016500
Jun 20161203
Jul 20161700
Aug 2016800
Sep 2016801
Oct 20161300
Nov 2016702
Dec 2016900
Jan 2017800
Feb 20171703
Mar 20171000
Apr 2017901
May 20172302
Jun 20173208
Jul 2017600
Aug 2017601
Sep 20171201
Oct 20171600
Nov 20171200
Dec 20171600
Jan 2018800
Feb 2018700
Mar 20181401
Apr 20181200
May 20181801
Jun 20182001
Jul 20181400
Aug 20181200
Sep 20182001
Oct 20182000
Nov 2018600
Dec 2018600
Jan 2019200
Feb 2019400
Mar 2019400
Apr 2019400
May 2019201
Jun 2019801
Jul 2019200
Aug 2019601
Oct 2019100
Nov 2019400
Dec 2019500
Jan 2020301
Mar 20201600
Apr 2020601
May 2020201
Jun 2020100
Jul 2020200
Aug 2020200
Sep 20201800
Oct 2020400
Nov 20201100
Dec 20201201
Jan 20211000
Feb 2021600
Mar 2021500
Apr 2021600
Sep 2021100
Oct 2021800
Nov 2021800
Dec 20212601
Jan 2022800
Feb 2022800
Mar 2022600
Apr 20221300
May 20222603
Jun 2022200
Jul 20221600
Aug 20221200
Sep 2022400
Oct 2022400
Nov 20221002
Dec 2022600
Feb 2023600
Mar 2023800
Apr 2023700
May 20231000
Jul 20233000
Aug 2023300
Sep 20232800
Dec 2023600
Mar 2024200
Total1044062